Cervical Ripening Balloon for 12 Hours vs. 1 Hour.
Launched by RAMBAM HEALTH CARE CAMPUS · Jun 18, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how long a special device called a cervical ripening balloon should be left in place to help women prepare for labor. The researchers want to compare the effects of leaving the balloon in for one hour versus twelve hours to see which option leads to a quicker delivery. Women who are getting ready to give birth and are admitted for labor induction may have the chance to participate in this study.
To be eligible, participants should be between the ages of 18 and 45 and at least 37 weeks pregnant. They can be first-time mothers or have had children before. However, women with certain conditions, like those who cannot have a vaginal delivery or are expecting multiple babies, will not be included. If you decide to join the trial, after the balloon is removed, the doctors will decide how to manage the delivery based on their professional judgment. This study is not yet recruiting, but it's an opportunity to contribute to important research on labor induction.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Nulliparous or multiparous gravidas
- • 2. Gestational age ≥ 370/7 to 416/7 gestational weeks
- • 3. Age 18-45
- • 4. Signed informed consent
- Exclusion Criteria:
- • 1. Contraindications for vaginal delivery
- • 2. Multifetal gestation
- • 3. Rupture of membranes
- • 4. Bishop score \> 6
- • 5. The cervix is dilated to more than 2 cm
- • 6. Previous caesarean delivery
About Rambam Health Care Campus
Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Naphtali Justman
Principal Investigator
Rambam Health Care Campus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported